Literature DB >> 32092666

Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.

Tung Tran1, Ramakanth Kavuluru2.   

Abstract

BACKGROUND: CBD products have risen in popularity given CBD's therapeutic potential and lack of legal oversight, despite lacking conclusive scientific evidence for widespread over-the-counter usage for many of its perceived benefits. While medical evidence is being generated, social media surveillance offers a fast and inexpensive alternative to traditional surveys in ascertaining perceived therapeutic purposes and modes of consumption for CBD products.
METHODS: We collected all comments from the CBD subreddit posted between January 1 and April 30, 2019 as well as comments submitted to the FDA regarding regulation of cannabis-derived products and analyzed them using a rule-based language processing method. A relative ranking of popular therapeutic uses and product groups for CBD is obtained based on frequency of pattern matches including precise queries that entail identifying mentions of the condition, a CBD product, and some "trigger" phrase indicating therapeutic use. We validated the social media-based findings using a similar analysis on comments to the U.S. Food and Drug Administration's (FDA) 2019 request-for-comments on cannabis-derived products.
RESULTS: CBD is mostly discussed as a remedy for anxiety disorders and pain and this is consistent across both comment sources. Of comments posted to the CBD subreddit during the monitored time span, 6.19% mentioned anxiety at least once with at least 6.02% of these comments specifically mentioning CBD as a treatment for anxiety (i.e., 0.37% of total comments). The most popular CBD product group is oil and tinctures.
CONCLUSION: Social media surveillance of CBD usage has the potential to surface new therapeutic use-cases as they are posted. Contemporary social media data indicate, for example, that stress and nausea are frequently mentioned as therapeutic use cases for CBD without corresponding evidence, that affirms or denies, in the research literature. However, the abundance of anecdotal claims warrants serious scientific exploration moving forward. Meanwhile, as FDA ponders regulation, our effort demonstrates that social data offers a convenient affordance to surveil for CBD usage patterns in a way that is fast and inexpensive and can inform conventional electronic surveys.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CBD; Cannabidiol; Cannabis; Hemp oil; Social media surveillance; Text mining

Mesh:

Substances:

Year:  2020        PMID: 32092666      PMCID: PMC7153970          DOI: 10.1016/j.drugpo.2020.102688

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  9 in total

1.  Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings.

Authors:  Meredith C Meacham; Michael J Paul; Danielle E Ramo
Journal:  Drug Alcohol Depend       Date:  2018-05-01       Impact factor: 4.492

2.  The Opportunity of CBD - Reforming the Law.

Authors:  Pieter A Cohen; Joshua Sharfstein
Journal:  N Engl J Med       Date:  2019-06-12       Impact factor: 91.245

3.  The value of unsolicited online data in drug policy research.

Authors:  Oskar Enghoff; Judith Aldridge
Journal:  Int J Drug Policy       Date:  2019-01-31

Review 4.  A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.

Authors:  C Michael White
Journal:  J Clin Pharmacol       Date:  2019-02-07       Impact factor: 3.126

5.  Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use.

Authors:  Michael J Paul; Margaret S Chisolm; Matthew W Johnson; Ryan G Vandrey; Mark Dredze
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

Review 6.  On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements.

Authors:  Peter S Cogan
Journal:  Expert Rev Clin Pharmacol       Date:  2019-05-07       Impact factor: 5.045

7.  "I feel like I've hit the bottom and have no idea what to do": Supportive social networking on Reddit for individuals with a desire to quit cannabis use.

Authors:  Shaina J Sowles; Melissa J Krauss; Lewam Gebremedhn; Patricia A Cavazos-Rehg
Journal:  Subst Abus       Date:  2017-07-13       Impact factor: 3.716

8.  Enhancing disease surveillance with novel data streams: challenges and opportunities.

Authors:  Benjamin M Althouse; Samuel V Scarpino; Lauren Ancel Meyers; John W Ayers; Marisa Bargsten; Joan Baumbach; John S Brownstein; Lauren Castro; Hannah Clapham; Derek At Cummings; Sara Del Valle; Stephen Eubank; Geoffrey Fairchild; Lyn Finelli; Nicholas Generous; Dylan George; David R Harper; Laurent Hébert-Dufresne; Michael A Johansson; Kevin Konty; Marc Lipsitch; Gabriel Milinovich; Joseph D Miller; Elaine O Nsoesie; Donald R Olson; Michael Paul; Philip M Polgreen; Reid Priedhorsky; Jonathan M Read; Isabel Rodríguez-Barraquer; Derek J Smith; Christian Stefansen; David L Swerdlow; Deborah Thompson; Alessandro Vespignani; Amy Wesolowski
Journal:  EPJ Data Sci       Date:  2015-10-16       Impact factor: 3.184

9.  A Cross-Sectional Study of Cannabidiol Users.

Authors:  Jamie Corroon; Joy A Phillips
Journal:  Cannabis Cannabinoid Res       Date:  2018-07-01
  9 in total
  8 in total

1.  Therapeutic Claims in Cannabidiol (CBD) Marketing Messages on Twitter.

Authors:  Mohammad Soleymanpour; Sofia Saderholm; Ramakanth Kavuluru
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2022-01-14

2.  What are the informational pathways that shape people's use of cannabidiol for medical purposes?

Authors:  Marco A Zenone; Jeremy Snyder; Valorie A Crooks
Journal:  J Cannabis Res       Date:  2021-05-06

3.  Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems.

Authors:  Julie Moltke; Chandni Hindocha
Journal:  J Cannabis Res       Date:  2021-02-18

4.  Infodemiological Examination of Personal and Commercial Tweets About Cannabidiol: Term and Sentiment Analysis.

Authors:  Mehmed Kantardzic; Rachel Vickers-Smith; Jason Turner
Journal:  J Med Internet Res       Date:  2021-12-20       Impact factor: 5.428

Review 5.  Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.

Authors:  Gerhard Nahler
Journal:  Pharmaceut Med       Date:  2022-03-04

6.  Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels.

Authors:  Han-Xiong Bear Zhang; Bruce P Bean
Journal:  J Neurosci       Date:  2021-06-15       Impact factor: 6.167

Review 7.  Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?

Authors:  Saoirse E O'Sullivan; Carl W Stevenson; Steven R Laviolette
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-12

8.  Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.

Authors:  Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.